Delivery Order SPE2DB20D2014-SPE2DB24FC86N

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $11,578.02 firm-fixed-price contract is for the supply of OTEZLA 30 MG TABLET 60S medication. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OTEZLA 30 MG TABLET 60S. The contract has a ceiling value of $27,980.55 and a completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4564732959 OTEZLA 30 MG TABLET 60S, a specialty medication, with a ceiling value of $9,086.24 and a performance period through May 29, 2024. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,134.54 firm-fixed-price contract is for the delivery of 4566211321 - OTEZLA 30 MG TABLET 60S, which is a prescription medication. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $26,951.38 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTEZLA 30 MG TABLET 60S. The contract has an ultimate completion date of June 5, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a $26,440.73 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565952697 - OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has a period of performance through September 27, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as well as multiple Indefinite Delivery Contracts...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $10,222.75, is for the delivery of 4563971313 OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price of $53,065.31 and a completion date of June 24, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $8,342.42 firm-fixed-price contract is for the supply of OTEZLA 30 mg tablets. The delivery order was placed under a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment...
This $3,421.31 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on October 11, 2024. The contract provides for the delivery of 4566087989 OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a period of performance through October 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, was awarded this order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC86N
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $13,353.55, is for the delivery of 4565598895 OTEZLA 30 MG TABLET 60S, with a completion date of August 28, 2024. It is a firm fixed-price contract under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation.

Generated 11/26/24, 9:02 AM